Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Additionally, new indications such as addiction, peripheral vascular disease, type 1 diabetes, metabolic liver disease, and neurodegenerative disorders are under clinical evaluation
Libyan J Med (2018) 13(1):1500346
L- ,
The Danish pharma company announced this morning that it will roll out what its calling the first multimonth subscription program for an FDA-approved obesity drug, offering Wegovy at a fixed monthly price that features savings of up to $1,200 a year for self-pay patients
Keep in mind that your healthcare team can provide guidance on potential financial assistance programs or options that may be available to help manage the cost of the medication
US$ 28.43
US$ 22.36
US$ 26.62
